Semaglutide was originally created to treat patients with diabetes, however, a secondary application was later found as a medicine used for weight loss, to lower blood sugar levels, and to reduce the risk of major cardiovascular events such as heart attack or stroke in type two diabetes patients
Research shows that most people experience a specific sequence of fat loss, beginning with deeper abdominal fat that surrounds internal organsa metabolically beneficial pattern
Semaglutide, the active ingredient in drugs like Ozempic and Wegovy , produces an average weight loss of 15% over the course of a year and a half
doi:10.1056/NEJMoa1615692 Although not directly focused on semaglutide, this study compared the long-acting insulin analog degludec with glargine in patients with type 2 diabetes and might provide insights into blood pressure effects of different glucose-lowering therapies
Heres how oral semaglutide, also known as Wegovy tablets, compares with Foundayo